| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LianBio | Director | Ordinary Shares | 17.1K | $81.3K | $4.76 | Feb 15, 2024 | Direct |
| Lyra Therapeutics, Inc. | Director | Stock Option | 30K | Jun 13, 2024 | Direct | ||
| LianBio | Director | Stock Option (Right to Buy) | 0 | Feb 15, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ARYD | ARYA Sciences Acquisition Corp IV | Jul 31, 2024 | 0 | $0 | 4 | Jul 31, 2024 | Chief Business Officer |
| LYRA | Lyra Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| LIAN | LianBio | Feb 15, 2024 | 3 | -$2 | 4 | Feb 20, 2024 | Director |
| LYRA | Lyra Therapeutics, Inc. | Jun 30, 2023 | 1 | $0 | 4 | Jul 5, 2023 | Director |
| LIAN | LianBio | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| LIAN | LianBio | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
| LYRA | Lyra Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
| LIAN | LianBio | Oct 29, 2021 | 0 | $0 | 3 | Oct 29, 2021 | Director |
| ARYE | ARYA Sciences Acquisition Corp V | Jul 12, 2021 | 0 | $0 | 3 | Jul 12, 2021 | Chief Business Officer |
| LYRA | Lyra Therapeutics, Inc. | May 26, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |